Navigation Links
CBLPath Opens Manhattan Facility
Date:5/28/2009

New location brings laboratory services closer to Metropolitan area physicians

Rye Brook, N.Y. (PRWEB) May 28, 2009 -- CBLPath, Inc., one of the nation's fastest-growing providers of specialized anatomic pathology services, today announced the opening of its Manhattan Facility as part of the company's continuous effort to enhance services for Metropolitan area physicians. Licensed by the New York State Department of Health (NYSDOH), the new facility is located at 400 East 66th Street, Suite 2D, and augments CBLPath's state-of-the-industry 66,000-square-foot main laboratory facility, which is located at 760 Westchester Avenue in Rye Brook, N.Y.

"We're very pleased to be able to bring our laboratory services closer to our physician-clients' practices," said Madeline Vazquez, M.D., Associate Director of the Manhattan Facility.

To find out more about the CBLPath Manhattan Facility, contact the company's Client Services Department or your local sales and service representative at 877.CBLPath (877.225.7284).

CBLPath, Inc. is a landmark anatomic pathology laboratory that delivers state-of-the-industry diagnostic testing and innovative technology solutions to its physician-clients across the nation. Founded in 1988 as Cytopath Biopsy Lab, CBLPath quickly established a reputation for providing timely and highly accurate diagnoses along with extraordinary customer service and a true patient-centered commitment. Additional information about the company is available by visiting CBLPath.com.

This news release may contain forward-looking statements (as delineated in the Private Securities Litigation Reform Act of 1995), which are based on the expectations, projections and beliefs of company management at the time of pronouncement. Some forward-looking statements may be identified by the use of such terms as "believes," "anticipates," "may," "intends," "plans," "estimates," "projects" and "expects." The company takes no obligation to update or revise any such statements after the date on which they are made. Forward-looking statements are subject to a wide range of risks and uncertainties that can cause actual results to differ materially from anticipated results. These variable factors include, but are not limited to, operating initiatives and acquisitions, general economic conditions, the competitive environment, federal and state laws and regulations (and changing interpretations thereof), reimbursement rates under government and third party healthcare programs and unanticipated expenditures. Accordingly, no assurance can be given as to the future financial condition, cash flow or results of operations of the company or any of its businesses. Further information regarding factors that could cause the company's results to differ from expectations is included in its annual reports.

###

Read the full story at http://www.prweb.com/releases/2009/05/prweb2462804.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. MDS Nordion Opens New Radiopharmaceutical Production Facility in Belgium
2. PRA International Opens Additional Drug Safety Center in Sao Paulo, Brazil
3. Alexian Brothers Medical Center Opens New Patient Tower
4. National Eyewear Chain Visionworks Opens Two New Stores in Orlando Market
5. National Eyewear Chain EyeMasters Opens Tenth Store in Cleveland Market
6. Law Offices of Bruce Egert Opens New Office in Hackensack
7. News media registration opens for ACS National Meeting in Washington, DC, Aug. 16-20
8. Medifast Weight Control Center Opens in Round Rock, TX
9. Research opens up new horizons to the design of customized medicines against breast cancer
10. As Kaiser Permanente Opens a New Hospital Wing, Security Officers Left Behind Without Affordable Healthcare
11. Hospital Opens New $19 Million Neonatal Intensive Care Unit
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CBLPath Opens Manhattan Facility
(Date:1/17/2017)... ... January 17, 2017 , ... Etymotic Research will demonstrate its ... Merchants (NAMM) winter trade show, Booth #2876, at the Anaheim Convention Center in ... the gold standard for high-definition, in-ear earphones. This classic earphone has been updated ...
(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, Houston’s premiere CoolSculpting ... Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, MD FACS, is delighted ... providers. , Produced by Zeltiq, CoolSculpting is approved by the Food and Drug ...
(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons from New York’s ... care practitioners on the latest breakthroughs in the prevention, diagnosis and treatment of ... according to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer of SightMD ...
(Date:1/17/2017)... ... ... Neil H. Greco Insurance Agency, a northern New Jersey firm that provides ... a charity drive to raise awareness of heart disease and promote habits that improve ... is responsible for 1 in every 4 deaths at the national level each year. ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley healthcare ... blind clinical study for its dental gel that shows significant reduction in plaque levels ... containing triclosan. The study was conducted at the Beckman Laser Institute at UC Irvine ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... -- OrthoAccel ® Technologies, Inc. announces that the ... Effect of Vibration on Molar Distalization," a study that ... Jay Bowman , this prospective, peer-reviewed clinical study concluded ... ® speeds up molar distalization rates in the ... days to move the upper molars into a normal, ...
(Date:1/17/2017)... 2017   Tocagen Inc ., a clinical-stage, cancer-selective gene therapy ... president, research and pharmaceutical development at Tocagen, will present at ... Jan. 17-20 in Miami . ... ... for replicating viruses - what to do when and why Date ...
(Date:1/17/2017)... Jan. 17, 2017  EMD Serono, the biopharmaceutical business ... in the U.S. and Canada , ... joined the company as Senior Vice President and Head ... Smith will oversee the Fertility and Endocrinology businesses in ... launched its first product last year with Gidget™, a ...
Breaking Medicine Technology: